Joel Greenblatt Relay Therapeutics, Inc. Transaction History

Gotham Asset Management, LLC

  • $7.56 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$6.01 - $11.48 $96,971 - $185,229
16,135 New
16,135 $177,000
Q4 2021

Feb 14, 2022
SELL
$26.0 - $37.03 $192,244 - $273,799
-7,394 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$29.75 - $37.99 $119,833 - $153,023
-4,028 Reduced 35.27%
7,394 $233,000
Q2 2021

Aug 16, 2021
BUY
$27.5 - $38.19 $314,105 - $436,206
11,422 New
11,422 $418,000

Others Institutions Holding RLAY

# of Institutions
183
Shares Held
127M
Call Options Held
1.7K
Put Options Held
18K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $780M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email